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Abstract
Background: Proteins associated with the late endosome (LE) appear to play a central role in the
envelopment of a number of taxonomically diverse viruses. How viral proteins interact with LE-
associated proteins to facilitate envelopment is not well understood. LE-derived transport vesicles
form through the interaction of Rab9 GTPase with cargo proteins, and TIP47, a Rab9-specific
effector protein. Vaccinia virus (VV) induces a wrapping complex derived from intracellular host
membranes to envelope intracellular mature virus particles producing egress-competent forms of
virus.
Results: We show that VV p37 protein associates with TIP47-, Rab9-, and CI-MPR-containing
membranes. Mutation of a di-aromatic motif in p37 blocks association with TIP47 and inhibits
plaque formation. ST-246, a specific inhibitor of p37 function, inhibits these interactions and also
blocks wrapped virus particle formation. Vaccinia virus expressing p37 variants with reduced ST-
246 susceptibility associates with Rab9 and co-localizes with CI-MPR in the presence and absence
of compound.
Conclusion:  These results suggest that p37 localizes to the LE and interacts with proteins
associated with LE-derived transport vesicle biogenesis to facilitate assembly of extracellular forms
of virus.
Background
Vaccinia virus (VV) is the prototypical member of
Orthopoxviridae, which replicates within the cytoplasm of
permissive cells. At least four distinct types of enveloped
infectious virus particles are produced during productive
infection: mature virus, also referred to as intracellular
mature virus or IMV, wrapped virus, also called intracellu-
lar enveloped virus (IEV), and two forms of extracellular
virus (EV), cell-associated enveloped virus (CEV), and
extracellular enveloped virus (EEV) [1,2]. IEV particles are
precursors of extracellular forms of virus and are created
by the wrapping of IMV particles in virus-modified mem-
branes [3,4]. Electron microscopic evidence suggests that
these membranes are derived from the TGN or post-TGN
vesicles [3,5].
Envelopment of IMV particles requires the activity of p37,
a highly conserved 37 kDa peripheral membrane protein
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encoded by the F13L gene [6]. Vaccinia p37 localizes to
the trans Golgi, plasma and endosomal membranes and is
shuttled between these various compartments through a
clathrin-mediated endosomal pathway [7]. Golgi localiza-
tion and intracellular trafficking of p37 requires palmit-
ylation of two cysteine residues at positions 185 and 186
[8] as well as a putative phospholipase motif composed of
histidine, lysine, aspartic acid (HKD) [5]. Targeted muta-
genesis of these cysteine residues or amino acids within
the HKD motif alters the intracellular distribution of p37
and inhibits IMV wrapping [9-12].
Vesicular transport and membrane trafficking are regu-
lated by Rab proteins which are small (20–29 kDa)
GTPases that belong to the Ras super family of proteins
[13]. GTP-bound Rab proteins serve in cargo selection and
act as scaffolds to nucleate vesicle assembly through inter-
actions with cargo and rab-specific effector proteins [13].
A number of viruses that derive their envelopes from
internal host membranes have been shown to interact
with host components associated with the late endosome
(LE) trafficking pathway [14-17]. The role of these virus-
host interactions in the formation of the virus membrane
is an area currently under investigation.
The LE is enriched for Rab9 protein that mediates recy-
cling of cation-dependent mannose-6-phosphate receptor
(CD-MPR) and cation-independent mannose-6-phos-
phate receptor (CI-MPR) from the LE to the trans Golgi
network (TGN) [18]. Rab9-dependent recycling of CI-
MPR is mediated through interactions with the tail inter-
acting protein of 47 kDa (TIP47), a Rab9-specific effector
[19,20]. TIP47 binds to a proline-rich motif found within
the C-terminus of CI-MPR [18] and a diaromatic tyrosine-
tryptophan (YW) motif found within the cytosolic tail of
CD-MPR [21]. Likewise, TIP47 has been shown to interact
with the HIV Env protein through a similar diaromatic YW
motif [22], as well as the MA domain of the HIV Gag pro-
tein by way of a 9-residue region situated at the N-termi-
nus [23]. RNAi-mediated depletion of Rab9 inhibited
replication of human immunodeficiency virus type 1, filo-
viruses, and measles virus, which is consistent with Rab9-
containing vesicles playing a role in virus assembly [16].
ST-246 is a small-molecule (MW = 376), potent pharma-
cological inhibitor of orthopoxvirus dissemination.
Genetic resistance to ST-246 maps to the V061 gene prod-
uct of cowpox virus, which is the homolog of VV p37 [24].
The small plaque phenotype observed in the presence of
compound and the ability of the compound to prevent
dissemination in vivo is consistent with the inhibition of
extracellular virus formation. Thus, ST-246 is a useful tool
for studying the mechanism of p37-dependent extracellu-
lar virus formation.
In this manuscript, plaque formation and wrapped virus
formation were found to be dependent upon interaction
of p37 with host LE-associated proteins in membrane
fractions of infected cells. The association of p37 with
Rab9 and CI-MPR but not, p230, a TGN-associated pro-
tein, could be inhibited by ST-246. Furthermore, muta-
tion of a diaromatic amino acid motif in p37 reduced the
interaction between p37 and TIP47 in membrane frac-
tions from infected cell lysates, thereby preventing the for-
mation wrapped virus particles. Taken together, these
results suggest that p37 interacts with host proteins
involved in LE trafficking to facilitate envelopment of IMV
particles.
Methods
Cell culture
RK-13, BSC-40, BGMK, and Vero cells were obtained from
American Type Culture Collection and maintained at
37°C and 5% CO2 in MEM medium (Invitrogen) supple-
mented with 10% fetal bovine serum (Invitrogen), 2 mM
glutamine (Invitrogen) and 10 μg/ml gentamicin (Invitro-
gen).
Antibodies
Immunofluorecent staining was performed using anti-
bodies against GM130, p230 (BD Biosciences Pharmin-
gen), and CI-MPR (Affinity BioReagents) at a
concentration of 20 μg/ml. The secondary antibody was
anti mouse-Alexa 594 (Molecular Probes) and was used at
a concentration of 1 μg/ml. Antisera against viral proteins,
B5 and L4, were generated at SIGA Technologies, Inc The
primary antibodies used for immunoprecipitation and
immunoblotting were: anti-CI-MPR (Affinity BioRea-
gents), p230, polyclonal anti-GFP (Invitrogen), mono-
clonal anti-GFP (BD BioSciences) and polyclonal TIP47
(C-20) (Santa Cruz BioTechnology, Inc). Secondary anti-
bodies included anti goat-HRP (Santa Cruz Biotechnolo-
gies), anti-mouse-HRP and anti-rabbit-HRP (Bio-Rad).
Buoyant density centrifugation of radiolabeled virions
RK-13 cells were seeded in two 150 cm2 diameter dishes at
1 × 107 cells per dish. The cultures were infected with 10
PFU/cell of vaccinia virus strain IHD-J in the absence or
presence of 10 μM ST-246. At 3 hours post infection (hpi)
the culture media was aspirated and replaced with thymi-
dine-deficient MEM containing 12 μCi/ml of [methyl-
3H]-thymidine (Amersham Biosciences GE Healthcare),
either in the presence or absence of 10 μM ST-246. At 24
hpi, the culture supernatants were centrifuged at 4000 × g
at 25°C for 5 min to remove cell debris. The supernatants
were layered onto a 7-ml cushion of 36% sucrose in PBS
and centrifuged at 40,000 × g at 4°C for 80 min. The pellet
(extracellular virus) was resuspended in 1 ml PBS and
stored on ice. BSC-40 cell monolayers were washed in 5
ml of PBS and harvested by scraping into 1 ml of hypot-Virology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
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onic buffer (50 mM Tris pH 8.0, 10 mM KCl) and allowed
to swell on ice for 10 min. The cells were subjected to two
freeze-thaw cycles and then homogenized by 20 strokes in
a Dounce homogenizer using a type-A pestle to release
virus. The cellular debris was removed by centrifugation at
700 × g for 10 min at 4°C. The supernatants were layered
on a 7-ml cushion of 36% sucrose in PBS and centrifuged
at 40,000 × g for 80 min at 4°C. The pellet (cell-associated
virus) was resuspended in 1 ml PBS and stored on ice.
Both extracellular and cell-associated samples were lay-
ered on top of preformed CsCl gradients. The gradients
were prepared in ultracentrifuge tubes by overlaying from
bottom to top 3 ml of 1.30 g/ml, 4 ml of 1.25 g/ml and 5
ml of 1.20 g/ml CsCl solution, respectively. The samples
were centrifuged at 100,000 × g for 3 hr at 15°C. Fractions
(500 μL) were collected from the bottom of each gradient.
Radiolabeled material from 20 μl of each fraction was
quantified by liquid scintillation counting.
Generation of recombinant VV
Marker rescue approach was used to generate vvF13L-GFP
as previously described [24]. Briefly, a gel-purified PCR
product of F13L-GFP containing 1 kb of flanking DNA
was co-transfected with genomic DNA of VV strain WR
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer's recommendations into BGMK cells
infected with 2 PFU/cell of Shope fibroma virus 1 h prior
to transfection. At 3 days post-transfection, progeny virus
was plated onto BSC-40 cells and GFP-positive foci were
isolated and subjected to three rounds of plaque purifica-
tion. In addition, an F13L-deletion virus (vvΔF13LGFP)
was created and purified as described above. In this
recombinant mutant virus, the GFP open reading frame
replaced the native F13L sequence following nucleotide
18.
Plasmid construction and site-directed mutagenesis
A gel-purified PCR product of F13L-GFP containing 1 kb
of flanking DNA (forward primer 5'-CATCCATC-
CAAATAACCCTAG-3'; reverse primer 5'-AGATACTCCTA-
GATACATACCATC-3') was TOPO cloned into pCR2.1
(Invitrogen) according to the manufacturer's instructions.
Selected residues underwent targeted mutagenesis using
the QuikChange®  Multi Site-Directed Mutagenesis Kit
(Stratagene) according to the manufacturer's instructions.
Mutagenesis primers were designed using the Quik-
Change® Primer Design Program (Stratagene). Plasmid
DNA was extracted using a QIAprep Spin Miniprep Kit
(Qiagen). Residue changes were verified by DNA sequenc-
ing.
Trans complementation assay
PCR products for transfection were prepared from each
mutant plasmid using forward primer 5'-CTCTAATCGT-
GGAGATGATGATAGTTTAAGC-3' and reverse primer 5'-
AGATACTCCTAGATACATACCATC-3'. PCR constructs
were purified using the QIAquick PCR Purification Kit
(Qiagen) and quantified by fluorometery. BSC-40 cells
were seeded into 6-well tissue culture plates at a density of
3 × 105 cells/ml one day prior to transfection and then
infected with 100 pfu/well of vvΔF13LGFP. At 1 hpi, the
viral inoculum was removed and replaced with 1.5 ml of
infection media. Transfections were carried out using 4 μg
of purified PCR product and 10 μl of Lipofectamine 2000
(Invitrogen) according to the manufacturer's recommen-
dations. Following an overnight incubation, the transfec-
tion inoculum was removed and replaced with 2.5 ml of
infection media containing 1.5% methylcellulose. On day
3 post-infection, the plates were fixed with 5% glutaralde-
hyde in PBS and stained with 0.5% crystal violet contain-
ing 5% methanol.
Subcellular fractionation
BSC-40 cells were infected with 5 PFU/cell of the wild type
recombinant virus, vvF13LGFP. At 12 hpi, cells were
washed once with PBS and harvested in 3 ml of HES
buffer containing a protease inhibitor cocktail (1 mM
EDTA, 250 mM sucrose, 20 mM HEPES, pH 7.4). The sus-
pension was pelleted by centrifugation at 700 × g at 4°C
for 5 min and the remaining volume was adjusted to 1.5
ml in HES buffer and passed 8 times through a 23 g needle
followed by Dounce homogenization. After centrifuga-
tion at 800 × g for 5 min, the cleared cell lysate was centri-
fuged at 4,000 × g for 10 min to generate a low speed
pellet and a low speed supernatant. The supernatant was
cleared of mature virion particles by loading 1.7 ml onto
a 36% sucrose cushion (Tris-HCl, pH 9.0) and subjected
to centrifugation at 34,380 × g for 55 min at 4°C using a
Beckman SW 60Ti rotor. The supernatant was collected
and further centrifuged at 350,000 × g for 30 min to gen-
erate a high speed pellet enriched for LE and microsomes.
The pelleted material was resuspended in 90 μl of HES
buffer containing a protease inhibitor cocktail and
divided in half. 45 μl was dedicated as the isolated mem-
brane fraction and used as input controls. The remaining
45 μl was employed in immunoprecipitation procedures.
Immunoprecipitation and immunoblotting
The protein content of each sample obtained from the
membrane fractionation was quantified by a protein assay
kit (Bio-Rad), adjusted to a concentration of 1 mg/ml and
then preadsorbed with 25 μl of protein A-Sepharose 4B
(50% slurry, Amersham Biosciences) at 4°C for 1 h to
reduce non-specific protein-bead interactions. The sam-
ples were centrifuged at 500 × g for 15 s to remove the pro-
tein A-Sepharose 4B beads. Primary antibody was added
to the supernatants to a final concentration of 2 μg/ml
and incubated at 4°C for 12 h. Antibody-bound com-
plexes were incubated with 40 μl of protein A-Sepharose
(50% slurry) for 4°C for 2 h. Immunoprecipitates wereVirology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
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collected by centrifugation at 500 × g for 15 sec and
washed four times with buffer. Immunoprecipitates were
resolved by 4–12% SDS-PAGE. Proteins were transferred
to nitrocellulose membranes (Hybond-C, Amersham)
and probed with specific antibodies to selected viral and
cellular targets. Immune complexes were detected using
ECL Western blotting detection kit (Amersham) according
to the manufacturer's instructions and exposed to MR-
type X-ray film (Kodak). Images for selected figures were
collected and processed using Adobe Photoshop software
followed by densitometry analysis using a BioRad Univer-
sal HoodII and Quantity I software package.
Immunofluorescence analysis and confocal microscopy
Chamber slides (Fisher Scientific) containing BSC-40 cells
were infected at 8 PFU per cell or transfected with 1 μg of
plasmid DNA per well using Lipofectamine 2000 (Invitro-
gen) in the presence and absence of 10 μM ST-246. At 12–
16 hpi, cells were washed in phosphate-buffered saline
(PBS), fixed in 4% paraformaldehyde for 15 min at 25°C,
rinsed with PBS, and permeabilized with 0.2% TritonX-
100 for 5 min. Slides were blocked with 10% goat serum
(Sigma Aldrich) in PBS for 30 min and then incubated for
1 h at 25°C with primary antibodies in goat serum-PBS.
Cells were washed with PBS, incubated for 30 min at
25°C with secondary antibodies in goat-serum-PBS fol-
lowed by three washes in PBS. The samples were mounted
in ProLong Gold Antifade Reagent (Invitrogen Molecular
Probes) containing DAPI to stain nuclear DNA. Analysis
was performed using a Zeiss LSM 510 confocal laser-scan-
ning microscope. Images were processed using LSM 510
Acquisition and Adobe Photoshop software.
ST-246
ST-246 was synthesized at Pharmacore, (High Point, NC)
and was dissolved in dimethyl sulfoxide (DMSO) (Sigma
Aldrich) to a concentration of 10 mM. Where indicated,
ST-246 was used at a concentration of 10 μM.
Results and discussion
ST-246 prevents the formation of wrapped viral particles
ST-246 targets VV p37 and has been shown to inhibit
plaque formation in vitro and prevent systemic viral
spread in vivo indicating that the compound inhibits the
release of extracellular virus [24]. To determine if the
block in EEV production was due to a lack of IEV produc-
tion, VV was propagated in the presence and absence of
ST-246, and virions were radiolabeled with tritiated thy-
midine and fractionated by equilibrium centrifugation
(Fig. 1A). In the absence of compound, radiolabeled
material from infected-cell lysates was partitioned into
three distinct peaks of radioactivity, while radiolabeled
material from the culture medium migrated as a single
peak. Based upon the solution density of the peak frac-
tions and immunoblot blot analysis, peaks from lysate
samples were designated IMV, CEV and IEV, respectively,
while the peak from the culture medium samples was des-
ignated EEV. In the presence of ST-246, only a single peak
of radioactivity was observed from the cell associated
virus fractions that migrated at the same density as IMV
particles and no peak of radioactivity could be detected in
virus from the culture medium. These results show that
ST-246 inhibits IEV and CEV formation but not IMV for-
mation during VV replication.
Immunoblot analysis of fractions from the equilibrium
centrifugation experiment was conducted to confirm the
identity of each type of viral particle in peak fractions.
Immunoblots were probed with anti-L4 antiserum to
detect viral cores and anti-B5 antiserum which is a compo-
nent specific to wrapped viral particles (Fig. 1B). In the
absence of ST-246, the L4 protein was detected in all frac-
tions with a density between 1.168 g/ml and 1.300 g/ml,
which is consistent with this protein being a component
of all forms of VV particles. B5 protein was detected in
fractions with a density between 1.168 g/ml and 1.250 g/
ml, suggesting that these fractions contained IEV and CEV
particles. In the presence of ST-246, L4 protein was
detected in fractions with a density between 1.250 g/ml
and 1.300 g/ml, while B5 protein was not detected in any
of the fractions. Taken together, these results demonstrate
that ST-246 inhibits wrapped virus formation and pre-
vents extracellular virus production.
p37 co-precipitates with TIP47 in infected cells
Plaque formation requires p37 activity that facilitates
wrapping of IMV in virus-modified membranes derived
from a post TGN-compartment to produce egress compe-
tent viral particles. A conserved YW motif (positions 253
and 254) was identified in the p37 protein that was iden-
tical to a motif found in HIV Env, the same motif shown
to mediate the association of Env with TIP47 [22]. In
order to establish whether or not p37 physically interacts
with TIP47, virion-free membrane fractions enriched for
LE-proteins were isolated from BSC-40 cells infected with
vvF13LGFP as described in the Material and Methods and
resuspended in a buffered solution containing a non-
ionic detergent. The fractions were then subjected to
immunoprecipitation using polyclonal antibodies to
either TIP47 (Fig. 2A, lanes 1 and 2), GFP (Fig. 2A, lanes
5 and 6), or TGN46 as a negative control (Fig. 2A, lanes 3,
4, 7, and 8). The immunoprecipitated proteins (Fig. 2A,
lanes 1, 3, 5 and 7) or supernatants (unbound fraction)
from the immunoprecipitation reaction mixtures (Fig. 2A,
lanes 2, 4, 6 and 8) were resolved by SDS-PAGE, trans-
ferred to a nitrocellulose membrane and probed with
either a monoclonal antibody to the GFP portion of the
p37-GFP fusion protein (left panel) or a polyclonal anti-
body to TIP47 (right panel). p37-GFP co-precipitated with
TIP47 (lane 1) and was also detected in the unbound frac-Virology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
Page 5 of 12
(page number not for citation purposes)
tion (lane 2). Likewise, TIP47 co-precipitated with p37-
GFP (lane 5), however, TIP47 was not detected in the
unbound fraction (lane 6) most likely because TIP47 is
primarily a soluble cytosolic protein and would not nor-
mally copurify with membrane fractions unless tethered
to a specific membrane associated cargo protein. A non-
specific band of approximately 55 kDa was also detected
in the blot probed with antibody to GFP and likely repre-
sents the heavy chain portion of the TGN46 antibody
employed in the immunprecipitation reaction (Fig. 2,
lane 3). p37 was found in the unbound fraction (Fig. 2,
lane 4) when polyclonal antibody specific for TGN46 was
used in the immunoprecipitation reactions while TIP47
could not be detected in the bound (Fig. 2, lane 7) or
unbound fractions (Fig. 2 lane 8). Taken together, these
results suggest that a physical interaction exists between
p37 and TIP47. While interaction of membrane proteins
in the presence of non-ionic detergent suggests direct
physical interaction, additional experiments are required
to prove specificity of this interaction.
To demonstrate antibody specificity, total cell lysates were
prepared from BSC40 cells that were either mock-infected
or infected with vvWR, vvGFP, vvΔF13LGFP, or
vvF13LGFP. A portion of the lysate was immunoprecipi-
tated with a polyclonal antibody to GFP. Immunoblots of
the lysate material pre- and post-immunoprecipitation
were probed with a monoclonal antibody to GFP (Fig.
2B). A band of approximately 66 kDa was observed on the
immunoblots in samples (Fig. 2B, lane 3 and 8) infected
with vvF13L-GFP migrating at the predicted size of the
p37-GFP fusion protein. A band of approximately 27 kDa
was observed in samples (Fig. 2B lane 4,5,9, and 10)
infected with vvGFP and vvΔF13LGFP corresponding to
the size of GFP. No bands were observed in mock-infected
samples (Fig. 2B lanes 1 and 6) or samples infected with
vvWR (Fig. 2B, lanes 2 and 7). These results suggest that
the both monoclonal and polyclonal antibodies specific
for GFP do not cross react with other viral and cellular
proteins.
Equilibrium centrifugation of radiolabeled virus particles in the presence and absence of ST-246 Figure 1
Equilibrium centrifugation of radiolabeled virus particles in the presence and absence of ST-246. Intracellular and 
extracellular virus particles were fractionated by equilibrium centrifugation on preformed cesium chloride gradients. (A) The 
radiolabeled viral DNA was measured by liquid scintillation counting. (B) The viral proteins in each fraction were detected by 
immunoblot analysis using antisera against L4 and B5 proteins. IMV, intracellular mature virus; CEV cell-associated enveloped 
virus; IEV, intracellular enveloped virus.Virology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
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A conserved YW motif within p37 is required for 
complimentation of an F13L-deletion virus
To determine whether the YW motif in p37 (Fig. 3A) is
required for interaction with TIP47, PCR-generated DNA
fragments of F13L containing alanine substitutions within
the YW motif were used to complement plaque formation
of an F13L-deleted virus. Co-immunoprecipitation was
then conducted to assess the ability of p37 expressed from
the mutated F13L alleles to associate with TIP47 in virion-
free membrane fractions obtained from infected cells.
Changing either Y or W to A at positions 253 and 254,
respectively, or both residues simultaneously (data not
shown) prevented co-immunoprecipitation of p37 with
TIP47 (Fig. 3C). In contrast, changing Y at position 253 to
phenylalanine to maintain the aromatic character of the
motif, or changing amino acids surrounding the YW motif
to A (residues 251, 252, and 255 – Fig. 3A) reduced the
association of p37 with TIP47 to varying degrees (Fig. 3C).
Introduction of these mutations did not alter the subcel-
lular localization of F13L in infected cells (see Additional
File 1).
VV recombinants containing deletions in F13L produced
normal levels of IMV particles but failed to form plaques
within a 3-day incubation period at 37°C. After a 7-day
incubation period plaques generated by F13L-deleted
recombinants were comparable in size to plaques gener-
ated by wild-type virus after a 1-day incubation period.
This strong plaquing phenotype was used to measure the
ability of mutated F13L alleles to complement plaque for-
mation of an F13L-deleted virus. Consistent with the co-
immunoprecipitation data presented in Fig. 3C, p37 vari-
ants containing alanine substitutions at either Y253 or
W254 respectively, were unable to complement plaque
formation of an F13L-deleted virus (Fig. 3B). Alanine sub-
stitutions at positions surrounding the YW motif did not
block complementation of the F13L-deleted virus (Fig.
3B) suggesting that the YW motif and not amino acids sur-
rounding this motif are required for extra cellular virus
formation. Complementing plaque formation by trans-
fecting PCR products encoding p37 could occur through
recombination of the F13L alleles into the viral genome or
by transient expression of active p37. This distinction,
however, does not affect the interpretation of the experi-
ment. Taken together, these observations suggest that the
aromatic nature of the YW motif is required for plaque
formation and that the YW motif contributes to the inter-
action of p37 with TIP47 in membrane fractions of
infected cells.
Confocal laser scanning microscopy was conducted to
rule out the possibility that the p37 expressed from the
Y253A and W254A mutants was mislocalized and no
longer capable of complementing plaque formation of
the F13L-deleted virus. BSC-40 cells were infected with
VV, strain WR, at an MOI of 1 and then transfected with
200 ng of PCR-generated DNA encoding wild-type or
mutant p37-GFP alleles. Approximately 50 to 100
infected and transfected cells per mutant construct were
evaluated for altered intracellular localization of p37-
GFP. The fluorescence profile obtained from the p37-GFP
fusion protein was evaluated against a TGN marker and
p37-GFP and TIP47 co-immunoprecipitate in the presence of  non-ionic detergent Figure 2
p37-GFP and TIP47 co-immunoprecipitate in the 
presence of non-ionic detergent. A. Membrane fractions 
from BSC-40 cells infected with vvF13LGFP at an MOI of 5 
were extracted as described in Materials and Methods. Pro-
tein extracts obtained from the high speed pellet were resus-
pended in a buffer containing a non-ionic detergent (0.5% 
NP-40, 150 mM NaCl, 20 mM Tris, pH7.4) and immunopre-
cipitated with antibodies specific for TIP47 or GFP followed 
by SDS-PAGE analysis and immunoblot. Antibody raised 
against the trans Golgi marker, TGN46 (Sigma Aldrich) was 
used as a non-specific control for immunoprecipitation. Lane 
1, IP using TIP47 pab; Lane 2, Unbound Fraction; Lane 3, IP 
using TGN46 pab; Lane 4, Unbound Fraction; Lane 5, IP using 
GFP pab, Lane 6, Unbound Fraction, Lane 7, IP using TGN46 
pab; Lane 8, Unbound Fraction; B. Immunoblot of whole cell 
extracts and membrane fractions immunoprecipitated with 
GFP pab from BSC-40 cells mock-infected or infected with 
vvWR, vvGFP, vvΔF13LGFP, or vvF13LGFP at an MOI of 5 
probed with GFP mab. Lane 1 and 6, mock-infected, Lane 2 
and 7, vvWR, Lane 3 and 8, vvF13LGFP, Lane 4 and 9, 
vvΔF13LGFP, Lane 5 and 10, vvGFP. IP, immunoprecipitated; 
pab, polyclonal antibody; mab, monoclonal antibody; ** 
pGFP; * p37-GFP fusion protein; † TIP47 protein.Virology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
Page 7 of 12
(page number not for citation purposes)
found to be indistinguishable from wild type p37 suggest-
ing that alanine substitution in and around the YW motif
does not alter the sub-cellular localization of p37 (Fig.
S1).
ST-246 inhibits association of p37-GFP with LE proteins in 
membrane fractions from infected cells
Based on the observations that the interaction of p37 with
TIP47 may be involved in plaque formation and that ST-
246, which targets p37 activity, inhibited wrapped virus
formation, the potential association of p37 with host pro-
teins known to be involved in Rab9-dependent vesicle for-
mation was evaluated. BSC-40 cells were mock-infected or
infected in the presence or absence of ST-246 with
vvF13LGFP, a recombinant virus that expresses a p37-GFP
fusion protein. The isolated membrane fraction was
immunoprecipitated in hypotonic buffer with anti-GFP to
pull out the p37-GFP-containing complexes. Immunoblot
analysis of the precipitated proteins using antibodies spe-
cific for Rab9 or the TGN resident protein, p230, was used
to measure the association of these proteins with p37. A
similar experiment was performed to measure the associ-
ation of CI-MPR with p37-GFP and Rab9. In the absence
of ST-246, immunoprecipitation of p37-GFP co-precipi-
tated p230 and Rab9 protein (Fig. 4A, Lane 1). Likewise,
immunoprecipitation of CI-MPR co-precipitated p37-GFP
and Rab9 (Fig. 4B, Lane 1). In the presence of ST-246, the
amount of p230 co-precipitating with p37-GFP remained
constant while the amount of Rab9 associated with p37-
GFP was undetectable (Fig. 4A, Lane 2). Similarly, the
amount of both p37-GFP and Rab9 co-precipitating with
CI-MPR was reduced in cells treated with ST-246 (Fig. 4B,
Lane 2). ST-246 did not affect the co-precipitation of Rab9
with CI-MPR in samples from mock-infected cells (Fig.
4C, Lanes 1 and 2). Taken together, these results imply
that ST-246 inhibits the interaction of p37-GFP with cel-
lular proteins associated with Rab9-dependent vesicle for-
mation but not proteins associated with the TGN in
membrane fractions from infected cells. Moreover, ST-246
does not alter the association of CI-MPR with Rab9 in
uninfected cells suggesting that the inhibitory effects of
ST-246 are virus-specific and not the result of an interfer-
ence with Rab9-dependent transport processes in unin-
fected cells.
ST-246 inhibits the co-localization of p37-GFP with LE 
proteins in the context of viral infection
To support the results of the co-immunoprecipitation
experiments, BSC-40 cells were infected with vvF13LGFP
in the presence and absence of ST-246 and the subcellular
localization of p37-GFP protein was determined by
immunofluorescence analysis and confocal microscopy.
The results of these studies are presented in Fig. 5 and con-
sist of images that are representative of a minimum of 50
Mutation of the YW motif in F13L blocks association of p37-GFP with TIP47 and prevents complementation of an F13L-deleted  virus Figure 3
Mutation of the YW motif in F13L blocks association of p37-GFP with TIP47 and prevents complementation of 
an F13L-deleted virus. (A) Diagram of the VV F13L gene with functional domains indicated. (B) Complementation experi-
ment demonstrating a panel of mutant F13L alleles containing the indicated A or F substitutions. The F13L allelescontained a 
GFP tag at the C-terminus to facilitate immunoprecipitation of p37. PCR products containing the indicated F13L allele were 
transfected into BSC-40 cells infected with an F13L-deletion virus. At 3 days post infection/transfection, plaques were visual-
ized by staining with crystal violet, (C) Membrane fractions, prepared as described in Materials and Methods, from infected and 
transfected cells were immunoprecipitated in hypotonic buffer with anti-GFP antibody and probed with TIP47 antibody (lower 
panel). The upper panel shows the input controls.Virology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
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infected cells. In the absence of ST-246, a discrete distribu-
tion of p37-GFP was observed, with no signal in the
nucleus (Fig. 5A). This signal co-localized with cellular
markers specific for GM130 (cis-Golgi) [25], p230
(TGN)[26], and CI-MPR (LE) [27] as shown by the pattern
of yellow in the merged images (Fig. 5 and data not
shown). These observations are in agreement with previ-
ous reports by other groups [3,5]. In the presence of ST-
246, however, p37-GFP co-localized with p230, with very
little, if any, co-localization with CI-MPR. Consistent with
the co-immunoprecipitation studies (Fig. 4), these obser-
vations suggest that ST-246 inhibits the intracellular traf-
ficking of the p37 protein to LE compartments in infected
cells. Thin-slice analysis (Z-stacks) by confocal micros-
copy further supported the above observation (data not
shown).
Since the effect of ST-246 on co-localization of p37-GFP
with LE proteins was observed in the context of virus
infection, it was important to determine whether this
effect required other viral proteins or was specific for p37.
Vero cells were transfected with the plasmid pSI-F13L-GFP
expressing p37-GFP in the presence or absence of ST-246
and analyzed by immunofluorescence and confocal
microscopy (Fig. 5B). The pattern of p37-GFP signal was
not affected by the presence of ST-246 and p37-GFP
appeared to co-localize with p230 and CI-MPR in the
presence and absence of ST-246 as measured by the inten-
sity of the yellow color of the merged images. These results
suggest that ST-246 inhibits a virus-specific activity
required for co-localization of p37 with LE proteins and is
consistent with the observation that functional p37 is
required for co-localization of the EEV-specific envelope
protein, B5, to post-Golgi vesicles [11].
ST-246 reduces p37-GFP association with vaccinia virus B5 
protein and LE proteins in membrane fractions from 
infected cells
The co-localization of p37 with B5 protein in infected
cells is thought to be an indicator of envelope precursor
formation [11]. To examine whether p37-GFP co-fraction-
ated with B5 and LE marker proteins, isolated membrane
fractions were subjected to co-immunoprecipitation in
hypotonic buffer with anti-GFP polyclonal antibody.
Immunoblot analysis of the isolated membrane fraction
prior to immunoprecipitation (input) showed the pres-
ence of the host factors CI-MPR, Rab9 and TIP47 as well
as the viral IEV component, B5 (Fig. 6, left panel), in the
presence and absence of ST-246. Immunoprecipitation of
the membrane fraction using antibodies to p37-GFP in
the absence of ST-246 co-precipitated CI-MPR, Rab9,
TIP47 and B5 (Fig. 6, right panel). In the presence of ST-
246, the amount of CI-MPR, Rab9 and TIP47 co-precipi-
tating with p37-GFP was greatly reduced and B5 was
undetectable. Although the membrane fractions were
cleared of intact virion particles by velocity sedimentation
as described the Materials and Methods, it is likely that
other viral components, particularly structural proteins,
which tend to be highly expressed, are present in the
membrane fraction but not associated with the p37-con-
taining membranes. To investigate this possibility, the iso-
lated membrane fraction was probed with antibodies
specific for the viral core proteins L4 and A27 both pre-
and post- immunoprecipitation. The A27 and L4 proteins
were detected in the input material (Fig. 6, left panel) in
the presence and absence of ST-246 but not in the com-
plex immunoprecipitated with antibody to p37-GFP (Fig.
6, right panel). This result suggests that these fractions
contain envelope precursors and viral core proteins, but
not intact IEV particles. These results suggest association
of LE proteins with p37- and B5-containing membrane
fractions is sensitive to inhibition by ST-246.
p37 expressed from an ST-246-resistant VV variant 
interacts with Rab9 and B5 in the presence and absence of 
compound
To confirm that inhibition of the association of LE pro-
teins with p37-containing membrane fractions by ST-246
is mediated through p37, BSC-40 cells were infected with
ST-246 affects the co-immunoprecipitation of membrane- associated p37-GFP, Rab9 and CI-MPR but not p230 Figure 4
ST-246 affects the co-immunoprecipitation of mem-
brane-associated p37-GFP, Rab9 and CI-MPR but not 
p230. BSC-40 cells were infected (A and B) with 5 PFU per 
cell of vvF13LGFP or mock-infected (C) in the absence (col-
umn 1) or presence (column 2) of 10 μM ST-246. The mem-
brane fractions were extracted as described in Materials and 
Methods, resuspended in hypotonic buffer and immunopre-
cipitated as indicated. Blots were probed with (A) p230 or 
Rab9 antibody, (B) GFP or Rab9 antibody, and (C) Rab9 anti-
body. The top row for each are input controls and are 
probed as indicated.Virology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
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wild type vvF13LGFP or an ST-246 resistant (ST-246R) var-
iant, which contains an Asp to Tyr change within the p37
protein. This amino acid change increases the concentra-
tion of compound required to inhibit 50% of the virus-
induced cytopathic effects (EC50) by more than 1000-fold.
The EC50 of ST-246 for wild-type VV is 50 nM while the
EC50 for the ST-246R variant is > 50 μM. Immunoblot
analysis of proteins immunoprecipitated with anti-GFP
polyclonal antibody from membrane fraction from wild
type virus-infected cells showed an association of p37
with Rab9 and B5 in the absence of ST-246. In the pres-
ence of ST-246, these interactions were nearly undetecta-
ble (Fig. 7A, left). In contrast, immunoblot analysis of
immunoprecipitated proteins from membrane fractions
of ST-246R variant virus-infected cells showed an associa-
tion of Rab9 and B5 with p37 in the presence and absence
of ST-246 (Fig. 7A, right). Densitometric analysis of the
immunoblots presented in Fig. 7A shows that the amount
of Rab9 and B5 that co-precipitate with p37-GFP in the
presence of ST-246 was greatly reduced in wild-type VV-
infected cells, compared to ST-246R virus-infected cells
(Fig. 7B).
To support the co-immunoprecipitation studies described
above, the intracellular localization of p37, p230, and CI-
MPR within cells infected by the ST-246R variant in the
presence and absence of ST-246 was examined by confo-
cal microscopy (Fig. 7C). The images presented are repre-
sentative of 50–100 infected cells throughout the entire
sample and were confirmed by thin-slice (Z-stack) analy-
sis. As observed in previous experiments (Fig. 4 and data
not shown), p37 co-localized with p230 in the presence
and absence of ST-246 (indicated by the pattern of yellow
in the merged images) (Fig. 7C, left). Moreover, unlike
p37 expressed from wild type vaccinia virus infected cells,
the p37 expressed from the ST-246R variant co-localized
with CI-MPR in the presence and absence of ST-246 (Fig.
7C, right). Taken together, these results suggest that ST-
246 inhibits the formation of a membrane complex con-
taining p37 and LE proteins.
Discussion
A prerequisite for production of extracellular forms of VV
is the assembly of IEV particles that involves wrapping of
IMV particles in virus modified membranes derived from
the host. Induction of this so-called wrapping complex,
also described as an envelope precursor membrane or a
post-TGN-vesicle, requires activities associated with the
p37 protein [28]. The wrapping complex incorporates
viral and cellular proteins that would normally co-localize
Co-localization of p37-GFP with p230 and CI-MPR in infected and uninfected cells in the presence and absence of ST-246 Figure 5
Co-localization of p37-GFP with p230 and CI-MPR in infected and uninfected cells in the presence and absence 
of ST-246. Cell monolayers were grown on chamber slides and (A) infected with 8 PFU/cell of vvF13LGFP or (B) transfected 
with 1 μg of plasmid expressing p37-GFP in the presence or absence of 10 μM ST-246. At 14–16 hpi cells were fixed in 4% 
paraformaldehyde, permeablized with 0.2% TritonX-100 and stained for 1 hour with anti-p230 antibody or anti-CI-MPR anti-
body. Proteins were visualized using Alexa 594-conjugated secondary antibody. Samples were mounted in ProLong Gold Anti-
fade Reagent (Invitrogen Molecular Probes) containing DAPI for nuclear staining and analyzed using a Zeiss LSM 510 confocal 
laser-scanning microscope. Images are representative of 2 separate experiments in which a minimum of 50 infected cells dis-
playing a similar fluorescent phenotype were observed. Images were collected and processed using LSM 510 acquisition and 
Adobe Photoshop software. Bar, 5 μm.Virology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
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to the Golgi and LE and is also enriched for selected viral
outer envelope proteins [1,5]. The wrapping complex is
thought to be the biologically active entity that enwraps
IMV particles to produce IEV particles [5,11]. In this man-
uscript, we show that induction of a membrane complex
containing viral p37 and B5 proteins and host LE proteins
involved in transport vesicle biogenesis requires interac-
tion of p37 with LE proteins and can be inhibited by ST-
246, a specific orthopoxvirus egress inhibitor.
The LE has been implicated as a potential source of mem-
branes for the formation of wrapped virus [4,11]. These
observations led us to focus on the involvement of pro-
teins associated with the LE in extracellular virus produc-
tion. Rab9 and TIP47 are both enriched in the LE and
form a scaffold for transport vesicle formation that shut-
tles CI-MPR from the LE to the Golgi. Immunoprecipita-
tion of p37-containing membrane fractions co-
precipitated TIP47 and Rab9. Targeted alanine (A) substi-
tutions of a conserved diaromatic (YW) motif in p37, the
same motif that has been shown to mediate the interac-
tion of TIP47 with HIV Env [22], blocked the association
of p37 with TIP47 in membrane fractions from infected
cells. Furthermore, A substitutions within the YW motif
that reduced interactions with TIP47 also failed to com-
ST-246 inhibits membrane precursor biogenesis Figure 6
ST-246 inhibits membrane precursor biogenesis. 
BSC-40 cells were infected with 5 PFU per cell of 
vvF13LGFP in the presence or absence of 10 μM ST-
246. Membrane extracts were prepared as described in 
Materials and Methods and analyzed by immunoblot (left 
panel). The remaining supernatant was then subjected to 
immunoprecipitation (right panel). Blots were probed with 
the indicated antibodies. Left panel, input controls; right 
panel, immunoprecipitated samples.
Co-immunoprecipitation and subcellular localization of Rab9  and B5 protein with p37-GFP expressed from vvF13LGFP or  an ST-246 resistant VV virus variant Figure 7
Co-immunoprecipitation and subcellular localization 
of Rab9 and B5 protein with p37-GFP expressed from 
vvF13LGFP or an ST-246 resistant VV virus variant. 
(A) BSC-40 cells were infected with wild type VV (left) or an 
ST-246-resistant variant that exhibits reduced susceptibility 
to ST-246 (right) in the presence or absence of 10 μM com-
pound. The membrane fractions were extracted as described 
in Materials and Methods, resuspended in hypotonic buffer 
and immunoprecipitated with anti-GFP polyclonal antibody. 
Blots were probed with Rab9 antibody or antiserum to B5 as 
indicated. Top row: input controls; (B) Quantitative compari-
son of immunoblot intensity in the absence and presence of 
ST-246; (C) Cell monolayers were grown on chamber slides 
and infected with 8 PFU/cell of an ST-246-resistant variant in 
the presence or absence of 10 μM ST-246. At 14–16 hpi cells 
were fixed in 4% paraformaldehyde, permeablized with 0.2% 
TritonX-100 and stained for 1 hour with anti-p230 antibody 
or anti-CI-MPR antibody. Proteins were visualized using 
Alexa 594-conjugated secondary antibody. Samples were 
mounted in ProLong Gold Antifade Reagent (Invitrogen 
Molecular Probes) containing DAPI for nuclear staining and 
analyzed using a Zeiss LSM 510 confocal laser-scanning 
microscope. Images are representative of experiments in 
which a minimum of 50 infected cells displaying a similar fluo-
rescent phenotype were observed. Images were collected 
and processed using LSM 510 acquisition and Adobe Pho-
toshop software. Bar, 5 μm.Virology Journal 2009, 6:44 http://www.virologyj.com/content/6/1/44
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plement plaque formation of an F13L-deleted virus.
Maintaining the diaromatic nature of the YW motif
retained the ability of TIP47 to associate with p37 and res-
cue the small plaque phenotype of the F13L-deleted virus
suggesting that the diaromatic nature of this motif is nec-
essary for extracellular virus formation. In addition, ST-
246 specifically blocked association of p37 with Rab9,
TIP47, and CI-MPR-containing membranes as well as
with the VV B5 protein but not p230, a TGN marker pro-
tein, in the context of viral infection. These data support a
model whereby p37-containing membranes associate
with host proteins required for induction of LE transport
vesicles to facilitate EV particle production.
The observation that the interaction between Rab9 and
CI-MPR appeared to be ST-246-sensitive only in the con-
text of viral infection suggests that Rab9-mediated trans-
port pathways are occupied by p37-dependent virus-
specific processes. Viral p37 is expressed at high levels and
represents a major source of cargo within the infected cell,
potentially sequestering available Rab9-containing mem-
branes to form the wrapping complex. By disrupting p37-
Rab9 interactions, ST-246 blocks the formation of a mem-
brane complex involved in EV biogenesis and perhaps
prevents Rab9-dependent vesicle formation and associa-
tion of cellular cargo, such as CI-MPR, with Rab9-contain-
ing membranes. While this phenomenon remains under
investigation, it exemplifies the high degree of specificity
of ST-246 for infected cells and may explain the observa-
tion that ST-246 has little or no toxicity in cell culture and
in animals.
The origin of the virus modified membranes that form the
wrapping complex has been controversial. Both the TGN
and endosomes have been implicated as the site of IMV
wrapping [3,4,11,28]. Immuno-EM studies have shown
that the virus-modified membrane system, which appears
as a double membrane structure 'modified' with viral
membrane proteins, could be stained with lectins specific
for glycoproteins that have been processed in the TGN but
not the cis or medial Golgi [3]. Moreover, Rab5 and Rab7,
proteins normally associated with early and late endo-
somes, respectively, were not found associated with wrap-
ping membranes [3]. These studies also show that
endocytic tracers (HRP and BSA-gold) were found in the
lumen of the wrapping cisternae. In addition, a number of
IMV particles could be found associated with endosomes.
Our data is consistent with these observations and sug-
gests that the virus modified membranes involved in EV
formation are derived from the late endosome and are
induced by interaction of p37 with LE proteins involved
in transport vesicle biogenesis.
Rab proteins are required for transport vesicle biogenesis
and are essential components of the membrane trafficking
system in the cell. Rab9 is predominantly localized to the
LE compartment and plays a role in cargo selection and
transport vesicle formation through interactions with
TIP47 [19,20]. RNAi-mediated disruption of this pathway
reduces replication of human immunodeficiency virus,
filoviruses, and measles virus suggesting a common
theme among diverse virus families that acquire their
envelope from this subcellular compartment [16].
Although RNAi-mediated knock-down of Rab9 or expres-
sion of dominant-negative mouse-specific Rab9 allele did
not inhibit plaque formation of VV, strain IHDJ (data not
shown), the association of p37 with LE components cor-
relates with induction of a p37-containing membrane
complex containing LE proteins and efficient plaque for-
mation. The inability to block plaque formation by inter-
fering with Rab9 expression or activity could be due to
residual Rab9 activity remaining after RNAi knock-down
or species incompatibility between dominant-negative
mouse Rab9 alleles and primate-specific host components
involved in membrane vesicle formation. Alternatively,
vaccinia virus may be less discriminating in the use of Rab
proteins and other host components involved in wrap-
ping complex formation. Indeed, vaccinia virus can use
multiple host kinases to facilitate release of cell-associated
extracellular virus into the extracellular space providing
precedent for this idea [29].
Conclusion
The p37 protein may participate directly in the biogenesis
of the wrapping complex through a conserved histidine-
lysine-aspartate (HKD) phospholipase motif that has
been shown to be essential for IMV wrapping. Targeted
mutagenesis of this motif or addition of a specific phos-
pholipase D inhibitor, reduced IMV wrapping and inhib-
ited extracellular particle formation [5,11]. This result
suggests that phospholipase activity is important for p37
function. Indeed, purified p37 has been shown to have
broad-spectrum lipase activity [30]. The role of lipase
activity in p37 function is unclear but may involve p37-
induced membrane alterations, since transfection studies
have shown that deletion of the HKD motif inhibited the
formation of p37-induced vesicles [11]. Whether or not
ST-246 inhibits the putative phospholipase activity is cur-
rently under investigation. Taken together, our results sug-
gest that p37-induced vesicle formation requires
association of p37 with host proteins associated with LE
transport vesicle biogenesis. Thus, p37 may interact with
LE proteins, mimicking cellular cargo, to nucleate a mem-
brane complex essential for the envelopment of IMV par-
ticles.
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